Suppr超能文献

[肝细胞癌肿瘤免疫中铁死亡调节的研究进展]

[Research progress on ferroptosis regulation in tumor immunity of hepatocellular carcinoma].

作者信息

Mo Yuqian, Zou Zhilin, Chen Erbao

机构信息

School of Public Health, Guangdong Medical University, Dongguan 523808, Guangdong Province, China.

Department of Hepatobiliary and Pancreatic Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, Guangdong Province, China.

出版信息

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 Dec 25;53(6):715-725. doi: 10.3724/zdxbyxb-2024-0117.

Abstract

Ferroptosis is a form of regulated cell death, which is dependent on iron metabolism imbalance and characterized by lipid peroxidation. Ferroptosis plays a crucial role in various pathological processes. Studies have shown that the occurrence of ferroptosis is closely associated with the progression of hepatocellular carcinoma (HCC). Ferroptosis is involved in regulating the lipid metabolism, iron homeostasis, mitochondrial metabolism, and redox processes in HCC. Additionally, ferroptosis plays a key role in HCC tumor immunity by modulating the phenotype and function of various immune cells in the tumor microenvironment, affecting tumor immune escape and progression. Ferroptosis-induced lipid peroxidation and oxidative stress can promote the polarization of M1 macrophages and enhance the pro-inflammatory response in tumors, inhibiting immune suppressive cells such as myeloid-derived suppressor cells and regulatory T cells to disrupt their immune suppression function. The regulation of expression of ferroptosis-related molecules such as GPX4 and SLC7A11 not only affects the sensitivity of tumor cells to immunotherapy but also directly influences the activity and survival of effector cells such as T cells and dendritic cells, further enhancing or weakening host antitumor immune response. Targeting ferroptosis has demonstrated significant clinical potential in HCC treatment. Induction of ferroptosis by nanomedicines and molecular targeting strategies can directly kill tumor cells or enhance antitumor immune responses. The integration of multimodal therapies with immunotherapy further expands the application of ferroptosis targeting as a cancer therapy. This article reviews the relationship between ferroptosis and antitumor immune responses and the role of ferroptosis in HCC progression from the perspective of tumor immune microenvironment, to provide insights for the development of antitumor immune therapies targeting ferroptosis.

摘要

铁死亡是一种受调控的细胞死亡形式,它依赖于铁代谢失衡,并以脂质过氧化为特征。铁死亡在各种病理过程中起着至关重要的作用。研究表明,铁死亡的发生与肝细胞癌(HCC)的进展密切相关。铁死亡参与调节HCC中的脂质代谢、铁稳态、线粒体代谢和氧化还原过程。此外,铁死亡通过调节肿瘤微环境中各种免疫细胞的表型和功能,影响肿瘤免疫逃逸和进展,在HCC肿瘤免疫中起关键作用。铁死亡诱导的脂质过氧化和氧化应激可促进M1巨噬细胞极化,增强肿瘤中的促炎反应,抑制髓源性抑制细胞和调节性T细胞等免疫抑制细胞,破坏其免疫抑制功能。对谷胱甘肽过氧化物酶4(GPX4)和溶质载体家族7成员11(SLC7A11)等铁死亡相关分子表达的调节不仅影响肿瘤细胞对免疫治疗的敏感性,还直接影响T细胞和树突状细胞等效应细胞的活性和存活,进一步增强或削弱宿主抗肿瘤免疫反应。靶向铁死亡在HCC治疗中已显示出显著的临床潜力。通过纳米药物和分子靶向策略诱导铁死亡可直接杀死肿瘤细胞或增强抗肿瘤免疫反应。多模态疗法与免疫疗法的整合进一步扩大了靶向铁死亡作为癌症治疗方法的应用。本文从肿瘤免疫微环境的角度综述了铁死亡与抗肿瘤免疫反应之间的关系以及铁死亡在HCC进展中的作用,为开发靶向铁死亡的抗肿瘤免疫疗法提供见解。

相似文献

1
[Research progress on ferroptosis regulation in tumor immunity of hepatocellular carcinoma].
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 Dec 25;53(6):715-725. doi: 10.3724/zdxbyxb-2024-0117.
2
APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy.
Cell Death Differ. 2024 Apr;31(4):431-446. doi: 10.1038/s41418-024-01270-0. Epub 2024 Feb 28.
3
Esculetin triggers ferroptosis via inhibition of the Nrf2-xCT/GPx4 axis in hepatocellular carcinoma.
Chin J Nat Med. 2025 Apr;23(4):443-456. doi: 10.1016/S1875-5364(25)60853-3.
6
New perspectives on ferroptosis and its role in hepatocellular carcinoma.
Chin Med J (Engl). 2022 Sep 20;135(18):2157-2166. doi: 10.1097/CM9.0000000000002327.
7
Ferroptosis in liver cancer: a key role of post-translational modifications.
Front Immunol. 2024 Apr 8;15:1375589. doi: 10.3389/fimmu.2024.1375589. eCollection 2024.
9
MCM4 potentiates evasion of hepatocellular carcinoma from sorafenib-induced ferroptosis through Nrf2 signaling pathway.
Int Immunopharmacol. 2024 Dec 5;142(Pt A):113107. doi: 10.1016/j.intimp.2024.113107. Epub 2024 Sep 13.

本文引用的文献

2
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
3
Dendritic Cells in Cancer Immunology and Immunotherapy.
Cancers (Basel). 2024 Feb 28;16(5):981. doi: 10.3390/cancers16050981.
5
ATF4 in cellular stress, ferroptosis, and cancer.
Arch Toxicol. 2024 Apr;98(4):1025-1041. doi: 10.1007/s00204-024-03681-x. Epub 2024 Feb 21.
8
TP53/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma.
J Immunother Cancer. 2023 Nov 29;11(11):e007479. doi: 10.1136/jitc-2023-007479.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验